"10.1371_journal.pone.0053936","plos one","2013-01-14T00:00:00Z","Elizabeth M King; Joanna E Chivers; Christopher F Rider; Anne Minnich; Mark A Giembycz; Robert Newton","Airways Inflammation Research Group, Snyder Institute for Chronic Diseases, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; Clinical Biomarkers Immunology, Bristol-Myers Squibb, Princeton, New Jersey, United States of America","Conceived and designed the experiments: EMK JEC RN. Performed the experiments: EMK JEC. Analyzed the data: EMK JEC CFR RN. Contributed reagents/materials/analysis tools: AM MAG RN. Wrote the paper: EMK JEC CFR AM MAG RN.","The authors have read the journals policy and have the following conflicts: This study was partly supported by funding from AstraZeneca and GlaxoSmithKline. AM is currently employed by Bristol-Myers Squibb and while at Aventis Pharmaceuticals (Bridgewater, NJ) was responsible for conducting the microarray profiling. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","01","Elizabeth M King","EMK",6,TRUE,3,2,4,6,TRUE,TRUE,FALSE,0,NA,FALSE
